Telerehabilitation for Lung Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Telerehabilitation for lung cancer?
Is telerehabilitation safe for humans?
Research shows that telerehabilitation is generally safe for people with lung cancer and other conditions like COPD (a lung disease that makes it hard to breathe). Studies suggest it can be as safe as traditional rehabilitation programs, but more research is needed to fully understand its long-term safety.12367
How is the treatment Telerehabilitation unique for lung cancer?
What is the purpose of this trial?
Lung cancer is the second-most commonly diagnosed cancer among U.S. Veterans. Substantial advances have been made in early detection through screening and treatment. The longevity of Veterans following lung cancer diagnosis and treatment has increased. Following treatment however, many Veterans experience increased symptom burden, particularly in shortness of breath, fatigue, and fear/anxiety about lung cancer, and impairments in physical and psychosocial functioning. Rehabilitation services are needed to address these survivorship challenges. This study will evaluate multi-targeted telerehabilitation with Veterans following lung cancer treatment, with goals to reduce symptom burden, improve physical and psychosocial function, and enhance health-related quality of life. This research will also develop the career of a physician researcher to acquire expertise in rehabilitation for many Veteran survivors of lung and other cancers.
Research Team
Duc M Ha, MD MAS
Principal Investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
Eligibility Criteria
This trial is for U.S. Veterans who have had stage I-IIIA lung cancer and finished their main treatment between 1-6 months ago. They must be able to follow directions and consent to the study, with a life expectancy over 6 months, no severe heart or lung disease, major orthopedic issues, or conditions that would stop them from doing exercises via telerehabilitation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of participant-chosen targeted telerehabilitation or waitlist condition
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Telerehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor